A13S (p.Ala13Ser) variant of EGFR (Epidermal growth factor receptor)

A13S (p.Ala13Ser) in EGFR (Epidermal growth factor receptor) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.13 / 1. The record also includes population frequency data and structural context.

A13S (p.Ala13Ser) variant details